全文获取类型
收费全文 | 28045篇 |
免费 | 2316篇 |
国内免费 | 920篇 |
专业分类
耳鼻咽喉 | 117篇 |
儿科学 | 468篇 |
妇产科学 | 432篇 |
基础医学 | 1963篇 |
口腔科学 | 299篇 |
临床医学 | 2996篇 |
内科学 | 6401篇 |
皮肤病学 | 443篇 |
神经病学 | 1508篇 |
特种医学 | 332篇 |
外国民族医学 | 6篇 |
外科学 | 2345篇 |
综合类 | 3030篇 |
现状与发展 | 14篇 |
预防医学 | 607篇 |
眼科学 | 474篇 |
药学 | 5824篇 |
13篇 | |
中国医学 | 693篇 |
肿瘤学 | 3316篇 |
出版年
2024年 | 50篇 |
2023年 | 562篇 |
2022年 | 825篇 |
2021年 | 1348篇 |
2020年 | 1168篇 |
2019年 | 1063篇 |
2018年 | 1057篇 |
2017年 | 1058篇 |
2016年 | 961篇 |
2015年 | 1060篇 |
2014年 | 1695篇 |
2013年 | 2604篇 |
2012年 | 1476篇 |
2011年 | 1703篇 |
2010年 | 1356篇 |
2009年 | 1352篇 |
2008年 | 1444篇 |
2007年 | 1341篇 |
2006年 | 1272篇 |
2005年 | 1147篇 |
2004年 | 928篇 |
2003年 | 820篇 |
2002年 | 649篇 |
2001年 | 535篇 |
2000年 | 416篇 |
1999年 | 382篇 |
1998年 | 328篇 |
1997年 | 318篇 |
1996年 | 257篇 |
1995年 | 256篇 |
1994年 | 199篇 |
1993年 | 176篇 |
1992年 | 145篇 |
1991年 | 163篇 |
1990年 | 153篇 |
1989年 | 119篇 |
1988年 | 105篇 |
1987年 | 63篇 |
1986年 | 77篇 |
1985年 | 107篇 |
1984年 | 99篇 |
1983年 | 72篇 |
1982年 | 73篇 |
1981年 | 74篇 |
1980年 | 50篇 |
1979年 | 37篇 |
1978年 | 42篇 |
1977年 | 25篇 |
1976年 | 21篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
目的探讨过氧化体增殖物激活型受体α(PPARα)的特异性激活物亚油酸对HepG2细胞1型纤溶酶原激活物抑制剂(PAI-1)mRNA表达及其活性的影响和在该基因转录调控中的作用机制.方法用不同浓度亚油酸为诱导因素刺激HepG2细胞,采用半定量RT-PCR法检测PAI-1mRNA水平,发色底物法检测PAI-1的活性变化.构建四个含PAI-1启动子序列从-804~+17间不同长度片段驱动的荧光素酶报告基因质粒,体外瞬时转染HepG2细胞,检测荧光素酶的活性.结果与对照组相比,亚油酸组能使HepG2细胞PAI-1mRNA表达及蛋白活性显著升高(P<0.05,P<0.01),且呈一定剂量依赖性;亚油酸诱导可使PAI-1转录活性显著升高(P<0.01);与转染质粒PAI-pGL3-A(-804/+17)相比较,当转染质粒含有PAI-pGL3-B(-636/+17)、PAI-pGL3-C(-449/+17)时,荧光素酶活性显著降低(P<0.01);共转染PPARα表达质粒(PPARα-pSG5)的细胞在亚油酸诱导下PAI-1转录活性显著升高(P<0.01).结论亚油酸可以增加HepG2细胞PAI-1mRNA表达及其蛋白活性,调节PAI-1的基因转录,PPARα参与亚油酸对PAI-1基因的表达调控;在PAI-1启动子-804~-636、-449~-276区域内存在亚油酸作用的调控PAI-1基因表达的序列. 相似文献
102.
When excluding haemophilia and von Willebrand disease, coagulation factors deficiencies constitute rare autosomal recessive disorders (<1 in 500,000) of less precisely defined epidemiology. We have reported herein the distribution of these entities in the French Basque Country, a genetic isolate of very old individualization with peculiar biological specificities. The prevalence of these disorders was markedly high, especially, as already shown, factor XI deficiency. This unusual profile needs to be discussed in the view of population genetics. 相似文献
103.
Summary. Patients with mild or moderate haemophilia A usually have a mild bleeding disorder requiring only occasional treatment with factor VIII (FVIII) concentrates. The frequency of inhibitor development in such patients has been the subject of several recent surveys, which significantly modified our appreciation of this complication. Studies of the anti-FVIII antibodies provided an explanation for the different bleeding phenotypes observed in mild/moderate haemophilia A patients with inhibitors. Antibodies distinguishing between the patient's mutant FVIII and the normal wild-type FVIII were characterized, in addition to antibodies inhibiting completely or only partially FVIII activity. T lymphocytes recognizing FVIII and likely involved in the development of the immune response to FVIII were successfully identified. The FVIII peptides recognized by those FVIII-specific cells bind to many major histocompatibility complex (MHC) class II molecules, which may provide an explanation for the lack of strong association between MHC haplotypes and inhibitor development. Although these studies have advanced our understanding of the conditions leading to inhibitor development, further work is required to determine whether the mode of FVIII administration significantly influences inhibitor development. Further studies of the genetic factors are also required to fully understand the mechanisms leading to inhibitor development in patients with mild/moderate haemophilia A. 相似文献
104.
105.
J. W. P. GOVERS-RIEMSLAG M. SMID J. A. COOPER† K. A. BAUER‡ R. D. ROSENBERG‡ C. E. HACK§ K. HAMULYAK¶ H. M. H. SPRONK G. J. MILLER† H. TEN CATE 《Journal of thrombosis and haemostasis》2007,5(9):1896-1903
BACKGROUND: The plasma kallikrein-kinin system (PKKS) has been implicated in cardiovascular disease, but activation of the PKKS has not been directly probed in individuals at risk of coronary heart disease (CHD) or stroke. OBJECTIVE: To determine the involvement of the PKKS, including factor XI, in cardiovascular disease occurring in a nested case-control study from the Second Northwick Park Heart Study (NPHS-II). METHODS AND RESULTS: After a median follow-up of 10.7 years, 287 cases of CHD and stroke had been recorded and 542 age-matched controls were selected. When FXIIa-C1 esterase inhibitor (C1-inhibitor) concentrations were divided into tertiles (lowest tertile as reference), the odds ratios (ORs) at 95% CIs for CHD were 0.52 (0.34-0.80) in the middle tertile and 0.73 (0.49-1.09) in the highest tertile (P = 0.01 for the overall difference; P = 0.01 for CHD and stroke combined). For kallikrein-C1-inhibitor complexes, the ORs for stroke were 0.29 (0.12-0.72) and 0.67 (0.30-1.52) in the middle and high tertiles, respectively (P = 0.02). FXIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes were negatively related to smoking and fibrinogen (P < 0.005). FXIa-inhibitor complexes correlated strongly with FXIIa-inhibitor complexes. CONCLUSIONS: Lower levels of inhibitory complexes of the PKKS enzymes and particularly of FXIIa contribute to the risk of CHD and stroke in middle-aged men. This observation supports the involvement of the PKKS in atherothrombosis. 相似文献
106.
高脂血症对血浆t-PA和PAI-1活性的影响 总被引:2,自引:0,他引:2
目的 探讨高脂血症患者的纤溶系统的变化。方法 选取正常人及高脂血症者,测定其血脂、血浆t—PA和PAI-1活性。结果 高脂血症组比正常人血浆t—PA活性下降,而PAI-1的活性有升高;在TG及LDL-C升高者,其血浆t—PA活性比正常人血浆t—PA活性降低,而血浆PAI-1活性比正常人升高;单纯TC升高者血浆PAI-1活性接近正常人组,而血浆t—PA活性比正常人组明显降低。结论 高脂血症对纤溶系统有一定的影响,其中甘油三酯和LDL-C对纤溶系统的影响更明显,而胆固醇对纤溶系统也有一定的影响。 相似文献
107.
Alex W Wilson Stephen J Medhurst Claire I Dixon Nick C Bontoft Lisa A Winyard Kim T Brackenborough Jorge De Alba Christopher J Clarke Martin J Gunthorpe Gareth A Hicks Chas Bountra Daniel S McQueen Iain P Chessell 《European Journal of Pain》2006,10(6):537-549
Clinically, inflammatory pain is far more persistent than that typically modelled pre-clinically, with the majority of animal models focussing on short-term effects of the inflammatory pain response. The large attrition rate of compounds in the clinic which show pre-clinical efficacy suggests the need for novel models of, or approaches to, chronic inflammatory pain if novel mechanisms are to make it to the market. A model in which a more chronic inflammatory hypersensitivity phenotype is profiled may allow for a more clinically predictive tool. The aims of these studies were to characterise and validate a chronic model of inflammatory pain. We have shown that injection of a large volume of adjuvant to the intra-articular space of the rat knee results in a prolonged inflammatory pain response, compared to the response in an acute adjuvant model. Additionally, this model also results in a hypersensitive state in the presence and absence of inflammation. A range of clinically effective analgesics demonstrate activity in this chronic model, including morphine (3mg/kg, t.i.d.), dexamethasone (1mg/kg, b.i.d.), ibuprofen (30mg/kg, t.i.d.), etoricoxib (5mg/kg, b.i.d.) and rofecoxib (0.3-10mg/kg, b.i.d.). A further aim was to exemplify the utility of this chronic model over the more acute intra-plantar adjuvant model using two novel therapeutic approaches; NR2B selective NMDA receptor antagonism and iNOS inhibition. Our data shows that different effects were observed with these therapies when comparing the acute model with the model of chronic inflammatory joint pain. These data suggest that the chronic model may be more relevant to identifying mechanisms for the treatment of chronic inflammatory pain states in the clinic. 相似文献
108.
2005~2007年我国非甾体抗炎药市场应用分析 总被引:1,自引:0,他引:1
目的:以骨骼肌肉系统使用非甾体抗炎药物为例,分析该类药物在2005~2007年的销售数量、销售金额及生产厂家风云榜。方法:采用药物分类累加的方法统计2005~2007年非甾体抗炎药的销售数量和金额排序,并对前10位药品销售数量和金额对比,及前10位厂家对比。结果:双氯芬酸稳居销售榜首,美洛昔康、布洛芬等药物位居其后。结论:新一代的非甾体抗炎药已经占据主要市场,各类药物各有特色,但是仍需注意其消化系统及心血管系统的不良反应。 相似文献
109.
E. Lanke A. M. Johansson A. Hillarp S. Lethagen B. Zller B. Dahlbck C. Halldn 《Journal of thrombosis and haemostasis》2004,2(11):1918-1923
Inherited deficiency of protein S constitutes an important risk factor of venous thrombosis. Many reports have demonstrated that causative mutations in the protein S gene are found only in approximately 50% of the cases with protein S deficiency. It is uncertain whether the protein S gene is causative in all cases of protein S deficiency or if other genes are involved in cases where no mutation is identified. The aim of the current study was to determine whether haplotypes of the protein S gene cosegregate with the disease phenotype in cases where no mutations have been found. Eight protein S-deficient families comprising 115 individuals where previous DNA sequencing had failed to detect any causative mutations were analyzed using four microsatellite markers in the protein S gene region. Co-segregation between microsatellite haplotypes and protein S deficiency was found in seven of the investigated families, one family being uninformative. This suggests that the causative genetic defects are located in or close to the protein S gene in a majority of such cases where no mutations have been found. 相似文献
110.